Sepraspray™ Laparoscopic Myomectomy Study

Laparoscopic Myomectomy Clinical Trial

Official title:
A Randomized, Masked Patient, Independent Reviewer, Multi-Center Pilot Study to Evaluate the Feasibility of Sepraspray™ Adhesion Barrier in Laparoscopic Myomectomy

Status Completed

Clinical Trial Summary

The purpose of this research study is to obtain preliminary data of the safety and effectiveness of Sepraspray in a limited number of patients who are under going a laparoscopic myomectomy. Sepraspray will be applied to the organs in the pelvic cavity following laparoscopic myomectomy. We will compare treatment with Sepraspray as a adhesion prevention barrier after laparoscopic myomectomy versus no adhesion barrier.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention

Related Conditions & MeSH terms

Laparoscopic Myomectomy

Clinical Trial Details

NCT number	NCT00624390
Study type	Interventional
Source	Sanofi
Contact
Status	Completed
Phase	N/A
Start date	November 2007
Completion date	December 2008

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04519593` - ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma	N/A
Terminated	`NCT01810900` - To Assess the Anti-adhesive Effect and Safety of Protescal	Phase 3
Terminated	`NCT03935815` - Quadratus Lumborum Nerve Blocks for Myomectomies	Phase 1
Completed	`NCT01530802` - Temporary Clipping of the Uterine Arteries During Laparoscopic Myomectomy	N/A
Recruiting	`NCT05154279` - The Effect of Intramyometrial Injection of Terlipressin Versus Intramyometrial Injection of Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy Operations	N/A
Terminated	`NCT00672750` - A Retrospective Review Of Outcomes Following Laparoscopic Myomectomy	N/A